ACROVAN, a global, drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug industries. ACROVAN offers clinical development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, clinical development programs. In addition, ACROVAN has developed technology tools for managing clinical trial data.

ACROVAN provides a positive outsourcing experience through the carefully managed application of industry expertise and effective management of client relationships.